Evidence map›Paper›PMID 32382571›Full record

ArticleBioMed research international2020

Mechanistic Understanding of Cell Recognition and Immune Reaction via CR1/CR3 by HAP- and SiO

Tingting Ding, Jiao Sun

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Tingting DingShanghai Biomaterials Research & Testing Center, Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, No. 427, Ju-men Road, Shanghai 200023, China.
Jiao SunShanghai Biomaterials Research & Testing Center, Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, No. 427, Ju-men Road, Shanghai 200023, China.ORCID https://orcid.org/0000-0002-2300-0500
Shanghai Ninth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanodrug carrier will eventually enter the blood when intravenously injected or in other ways. Meanwhile, a series of toxic effects were caused to the body with the formation of nanoparticle protein corona. In our studies, we try to reveal the recognition mechanism of nanoparticle protein corona by monocyte and the damage effect on immune cells by activated complement of hydroxyapatite nanoparticles (HAP-NPs) and silicon dioxide nanoparticles (SiO

Indexed as

Complement ActivationDurapatiteHumansHuman Umbilical Vein Endothelial CellsMacrophage-1 AntigenMonocytesNanoparticlesProtein CoronaReceptors, Complement 3bSilicon DioxideTHP-1 CellsToll-Like Receptor 4CR1 protein, humanDurapatiteMacrophage-1 AntigenProtein CoronaReceptors, Complement 3bSilicon DioxideTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID32382571
PMCPMC7195653
OpenAlexW3018200895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.